Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
4.960
-0.250 (-4.80%)
May 18, 2026, 4:00 PM EDT - Market closed
Annexon Employees
Annexon had 93 employees as of March 31, 2026. The number of employees decreased by 13 or -12.26% compared to the same quarter last year.
Employees
93
Change
-13
Growth
-12.26%
Revenue / Employee
n/a
Profits / Employee
-$2,132,613
Market Cap
812.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 93 | -13 | -12.26% |
| Dec 31, 2025 | 96 | -4 | -4.00% |
| Sep 30, 2025 | 99 | 15 | 17.86% |
| Jun 30, 2025 | 103 | 32 | 45.07% |
| Mar 31, 2025 | 106 | 36 | 51.43% |
| Dec 31, 2024 | 100 | 29 | 40.85% |
| Sep 30, 2024 | 84 | 8 | 10.53% |
| Jun 30, 2024 | 71 | -6 | -7.79% |
| Mar 31, 2024 | 70 | -10 | -12.50% |
| Dec 31, 2023 | 71 | -9 | -11.25% |
| Sep 30, 2023 | 76 | -7 | -8.43% |
| Jun 30, 2023 | 77 | 2 | 2.67% |
| Mar 31, 2023 | 80 | 17 | 26.98% |
| Dec 31, 2022 | 80 | 19 | 31.15% |
| Sep 30, 2022 | 83 | 21 | 33.87% |
| Jun 30, 2022 | 75 | 18 | 31.58% |
| Mar 31, 2022 | 63 | 15 | 31.25% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| Xencor | 260 |
| Geron | 258 |
| Aura Biosciences | 113 |
| ORIC Pharmaceuticals | 104 |
| Theravance Biopharma | 90 |
| Avalo Therapeutics | 33 |
| Arbutus Biopharma | 19 |
ANNX News
- 12 hours ago - Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 days ago - Annexon Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 days ago - Annexon initiated with a Neutral at Goldman Sachs - TheFly
- 7 days ago - 110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS - GlobeNewsWire
- 11 days ago - Annexon reports Q1 EPS (23c), consensus (30c) - TheFly
- 11 days ago - Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones - GlobeNewsWire
- 11 days ago - Annexon Quarterly report: Q1 2026 - Filings
- 11 days ago - Annexon Earnings release: Q1 2026 - Filings